Dermatologists' ethical obligations to patients and their family members regarding genetic testing
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Journal of the American Academy of Dermatology - (2023) vom: 19. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ferreira, Alana [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 12.07.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.jaad.2023.06.019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358452864 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358452864 | ||
| 003 | DE-627 | ||
| 005 | 20231226074754.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaad.2023.06.019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM358452864 | ||
| 035 | |a (NLM)37343828 | ||
| 035 | |a (PII)S0190-9622(23)01172-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ferreira, Alana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dermatologists' ethical obligations to patients and their family members regarding genetic testing |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 12.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a HIPAA | |
| 650 | 4 | |a communication | |
| 650 | 4 | |a confidentiality | |
| 650 | 4 | |a decision-making process | |
| 650 | 4 | |a disclosure | |
| 650 | 4 | |a duty to warn | |
| 650 | 4 | |a ethics | |
| 650 | 4 | |a familial atypical multiple mole melanoma syndrome | |
| 650 | 4 | |a family members | |
| 650 | 4 | |a genetic counseling | |
| 650 | 4 | |a genetic testing | |
| 650 | 4 | |a hereditary conditions | |
| 650 | 4 | |a informed consent | |
| 650 | 4 | |a legal considerations | |
| 650 | 4 | |a moral deliberation | |
| 650 | 4 | |a nonmaleficence | |
| 650 | 4 | |a patient autonomy | |
| 650 | 4 | |a preventive measures | |
| 650 | 4 | |a risk assessment | |
| 700 | 1 | |a Buckey, Timothy M |e verfasserin |4 aut | |
| 700 | 1 | |a Grant-Kels, Jane M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Academy of Dermatology |d 1984 |g (2023) vom: 19. Juni |w (DE-627)NLM000422703 |x 1097-6787 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:19 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaad.2023.06.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 19 |c 06 | ||